CLOROX COMPANY (CLX) Stock Fundamental Analysis

USA • New York Stock Exchange • NYSE:CLX • US1890541097

119.36 USD
+1.75 (+1.49%)
At close: Feb 6, 2026
117.687 USD
-1.67 (-1.4%)
After Hours: 2/6/2026, 8:25:32 PM
Fundamental Rating

4

Overall CLX gets a fundamental rating of 4 out of 10. We evaluated CLX against 12 industry peers in the Household Products industry. While CLX is still in line with the averages on profitability rating, there are concerns on its financial health. CLX is quite expensive at the moment. It does show a decent growth rate. CLX also has an excellent dividend rating.


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

  • CLX had positive earnings in the past year.
  • In the past year CLX had a positive cash flow from operations.
  • CLX had positive earnings in each of the past 5 years.
  • In the past 5 years CLX always reported a positive cash flow from operatings.
CLX Yearly Net Income VS EBIT VS OCF VS FCFCLX Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B

1.2 Ratios

  • The Return On Assets of CLX (14.31%) is better than 91.67% of its industry peers.
  • The Return On Invested Capital of CLX (21.90%) is better than 83.33% of its industry peers.
  • CLX had an Average Return On Invested Capital over the past 3 years of 18.59%. This is above the industry average of 14.83%.
  • The 3 year average ROIC (18.59%) for CLX is below the current ROIC(21.90%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 14.31%
ROE N/A
ROIC 21.9%
ROA(3y)7.31%
ROA(5y)8.13%
ROE(3y)135.14%
ROE(5y)132.26%
ROIC(3y)18.59%
ROIC(5y)17.73%
CLX Yearly ROA, ROE, ROICCLX Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50 100 150 200 250

1.3 Margins

  • CLX's Profit Margin of 11.68% is fine compared to the rest of the industry. CLX outperforms 66.67% of its industry peers.
  • In the last couple of years the Profit Margin of CLX has declined.
  • CLX has a Operating Margin (15.17%) which is in line with its industry peers.
  • In the last couple of years the Operating Margin of CLX has declined.
  • Looking at the Gross Margin, with a value of 44.28%, CLX is in the better half of the industry, outperforming 66.67% of the companies in the same industry.
  • In the last couple of years the Gross Margin of CLX has remained more or less at the same level.
Industry RankSector Rank
OM 15.17%
PM (TTM) 11.68%
GM 44.28%
OM growth 3Y18.52%
OM growth 5Y-2.48%
PM growth 3Y20.6%
PM growth 5Y-3.98%
GM growth 3Y8.04%
GM growth 5Y-0.18%
CLX Yearly Profit, Operating, Gross MarginsCLX Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10 20 30 40

3

2. Health

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is well above the Cost of Capital (WACC), so CLX is creating value.
  • The number of shares outstanding for CLX has been reduced compared to 1 year ago.
  • Compared to 5 years ago, CLX has less shares outstanding
  • CLX has a worse debt/assets ratio than last year.
CLX Yearly Shares OutstandingCLX Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M 80M 100M
CLX Yearly Total Debt VS Total AssetsCLX Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B

2.2 Solvency

  • An Altman-Z score of 3.32 indicates that CLX is not in any danger for bankruptcy at the moment.
  • CLX's Altman-Z score of 3.32 is fine compared to the rest of the industry. CLX outperforms 75.00% of its industry peers.
  • The Debt to FCF ratio of CLX is 4.25, which is a neutral value as it means it would take CLX, 4.25 years of fcf income to pay off all of its debts.
  • With a Debt to FCF ratio value of 4.25, CLX is not doing good in the industry: 66.67% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF 4.25
Altman-Z 3.32
ROIC/WACC2.75
WACC7.97%
CLX Yearly LT Debt VS Equity VS FCFCLX Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B 2B 2.5B

2.3 Liquidity

  • CLX has a Current Ratio of 0.76. This is a bad value and indicates that CLX is not financially healthy enough and could expect problems in meeting its short term obligations.
  • CLX has a worse Current ratio (0.76) than 75.00% of its industry peers.
  • A Quick Ratio of 0.50 indicates that CLX may have some problems paying its short term obligations.
  • The Quick ratio of CLX (0.50) is worse than 91.67% of its industry peers.
Industry RankSector Rank
Current Ratio 0.76
Quick Ratio 0.5
CLX Yearly Current Assets VS Current LiabilitesCLX Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B 2B

4

3. Growth

3.1 Past

  • The earnings per share for CLX have decreased by -5.48% in the last year.
  • Measured over the past 5 years, CLX shows a small growth in Earnings Per Share. The EPS has been growing by 1.01% on average per year.
  • Looking at the last year, CLX shows a small growth in Revenue. The Revenue has grown by 0.16% in the last year.
  • Measured over the past years, CLX shows a small growth in Revenue. The Revenue has been growing by 1.11% on average per year.
EPS 1Y (TTM)-5.48%
EPS 3Y23.44%
EPS 5Y1.01%
EPS Q2Q%-10.32%
Revenue 1Y (TTM)0.16%
Revenue growth 3Y-0.01%
Revenue growth 5Y1.11%
Sales Q2Q%-0.77%

3.2 Future

  • Based on estimates for the next years, CLX will show a small growth in Earnings Per Share. The EPS will grow by 1.36% on average per year.
  • The Revenue is expected to grow by 1.10% on average over the next years.
EPS Next Y-22.86%
EPS Next 2Y-6.14%
EPS Next 3Y-2.27%
EPS Next 5Y1.36%
Revenue Next Year-7.99%
Revenue Next 2Y-1.73%
Revenue Next 3Y-0.22%
Revenue Next 5Y1.1%

3.3 Evolution

  • The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
  • The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
CLX Yearly Revenue VS EstimatesCLX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 2B 4B 6B 8B
CLX Yearly EPS VS EstimatesCLX Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 2 4 6 8 10

2

4. Valuation

4.1 Price/Earnings Ratio

  • A Price/Earnings ratio of 18.20 indicates a rather expensive valuation of CLX.
  • The rest of the industry has a similar Price/Earnings ratio as CLX.
  • Compared to an average S&P500 Price/Earnings ratio of 27.92, CLX is valued a bit cheaper.
  • Based on the Price/Forward Earnings ratio of 17.53, the valuation of CLX can be described as rather expensive.
  • Compared to the rest of the industry, the Price/Forward Earnings ratio of CLX is on the same level as its industry peers.
  • The average S&P500 Price/Forward Earnings ratio is at 27.78. CLX is valued slightly cheaper when compared to this.
Industry RankSector Rank
PE 18.2
Fwd PE 17.53
CLX Price Earnings VS Forward Price EarningsCLX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

  • CLX's Enterprise Value to EBITDA ratio is in line with the industry average.
  • Based on the Price/Free Cash Flow ratio, CLX is valued a bit more expensive than 66.67% of the companies in the same industry.
Industry RankSector Rank
P/FCF 22.89
EV/EBITDA 13.35
CLX Per share dataCLX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 40

4.3 Compensation for Growth

  • The decent profitability rating of CLX may justify a higher PE ratio.
  • A cheap valuation may be justified as CLX's earnings are expected to decrease with -2.27% in the coming years.
PEG (NY)N/A
PEG (5Y)17.96
EPS Next 2Y-6.14%
EPS Next 3Y-2.27%

7

5. Dividend

5.1 Amount

  • With a Yearly Dividend Yield of 4.21%, CLX is a good candidate for dividend investing.
  • Compared to an average industry Dividend Yield of 2.56, CLX pays a better dividend. On top of this CLX pays more dividend than 83.33% of the companies listed in the same industry.
  • Compared to an average S&P500 Dividend Yield of 1.83, CLX pays a better dividend.
Industry RankSector Rank
Dividend Yield 4.21%

5.2 History

  • The dividend of CLX has a limited annual growth rate of 2.88%.
  • CLX has paid a dividend for at least 10 years, which is a reliable track record.
  • CLX has not decreased their dividend for at least 10 years, which is a reliable track record.
Dividend Growth(5Y)2.88%
Div Incr Years34
Div Non Decr Years34
CLX Yearly Dividends per shareCLX Yearly Dividends per shareYearly Dividends per share 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 1 2 3 4

5.3 Sustainability

  • CLX pays out 76.11% of its income as dividend. This is not a sustainable payout ratio.
  • The dividend of CLX is growing, but the earnings are growing slower. This means the dividend growth is not sustainable.
DP76.11%
EPS Next 2Y-6.14%
EPS Next 3Y-2.27%
CLX Yearly Income VS Free CF VS DividendCLX Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M 1B
CLX Dividend Payout.CLX Dividend Payout, showing the Payout Ratio.CLX Dividend Payout.PayoutRetained Earnings

CLOROX COMPANY

NYSE:CLX (2/6/2026, 8:25:32 PM)

After market: 117.687 -1.67 (-1.4%)

119.36

+1.75 (+1.49%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupHousehold & Personal Products
GICS IndustryHousehold Products
Earnings (Last)02-03
Earnings (Next)05-04
Inst Owners89.77%
Inst Owner Change-3.03%
Ins Owners0.4%
Ins Owner Change13.57%
Market Cap14.56B
Revenue(TTM)7.10B
Net Income(TTM)791.00M
Analysts54.81
Price Target123.8 (3.72%)
Short Float %6.14%
Short Ratio3.18
Dividend
Industry RankSector Rank
Dividend Yield 4.21%
Yearly Dividend4.88
Dividend Growth(5Y)2.88%
DP76.11%
Div Incr Years34
Div Non Decr Years34
Ex-Date01-28
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)17.83%
Min EPS beat(2)6.97%
Max EPS beat(2)28.7%
EPS beat(4)3
Avg EPS beat(4)9.13%
Min EPS beat(4)-8.29%
Max EPS beat(4)28.7%
EPS beat(8)7
Avg EPS beat(8)25.3%
EPS beat(12)11
Avg EPS beat(12)52.89%
EPS beat(16)13
Avg EPS beat(16)41.78%
Revenue beat(2)2
Avg Revenue beat(2)1.32%
Min Revenue beat(2)1.06%
Max Revenue beat(2)1.58%
Revenue beat(4)3
Avg Revenue beat(4)0.24%
Min Revenue beat(4)-4.3%
Max Revenue beat(4)2.62%
Revenue beat(8)5
Avg Revenue beat(8)1.13%
Revenue beat(12)9
Avg Revenue beat(12)2.28%
Revenue beat(16)11
Avg Revenue beat(16)1.58%
PT rev (1m)-1.2%
PT rev (3m)-9.01%
EPS NQ rev (1m)-1.5%
EPS NQ rev (3m)-5.25%
EPS NY rev (1m)-0.29%
EPS NY rev (3m)-0.74%
Revenue NQ rev (1m)-0.12%
Revenue NQ rev (3m)-0.66%
Revenue NY rev (1m)-0.09%
Revenue NY rev (3m)-0.17%
Valuation
Industry RankSector Rank
PE 18.2
Fwd PE 17.53
P/S 2.15
P/FCF 22.89
P/OCF 17.07
P/B N/A
P/tB N/A
EV/EBITDA 13.35
EPS(TTM)6.56
EY5.5%
EPS(NY)6.81
Fwd EY5.7%
FCF(TTM)5.21
FCFY4.37%
OCF(TTM)6.99
OCFY5.86%
SpS55.51
BVpS-0.18
TBVpS-14.84
PEG (NY)N/A
PEG (5Y)17.96
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA 14.31%
ROE N/A
ROCE 31.18%
ROIC 21.9%
ROICexc 22.99%
ROICexgc 49.37%
OM 15.17%
PM (TTM) 11.68%
GM 44.28%
FCFM 9.39%
ROA(3y)7.31%
ROA(5y)8.13%
ROE(3y)135.14%
ROE(5y)132.26%
ROIC(3y)18.59%
ROIC(5y)17.73%
ROICexc(3y)19.75%
ROICexc(5y)18.87%
ROICexgc(3y)40.28%
ROICexgc(5y)41.99%
ROCE(3y)24.92%
ROCE(5y)23.9%
ROICexgc growth 3Y25.21%
ROICexgc growth 5Y-4.26%
ROICexc growth 3Y28.43%
ROICexc growth 5Y1.01%
OM growth 3Y18.52%
OM growth 5Y-2.48%
PM growth 3Y20.6%
PM growth 5Y-3.98%
GM growth 3Y8.04%
GM growth 5Y-0.18%
F-Score6
Asset Turnover1.22
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF 4.25
Debt/EBITDA 2.17
Cap/Depr 98.19%
Cap/Sales 3.2%
Interest Coverage 250
Cash Conversion 68.35%
Profit Quality 80.4%
Current Ratio 0.76
Quick Ratio 0.5
Altman-Z 3.32
F-Score6
WACC7.97%
ROIC/WACC2.75
Cap/Depr(3y)95.76%
Cap/Depr(5y)111.24%
Cap/Sales(3y)3.06%
Cap/Sales(5y)3.44%
Profit Quality(3y)296.87%
Profit Quality(5y)227.9%
High Growth Momentum
Growth
EPS 1Y (TTM)-5.48%
EPS 3Y23.44%
EPS 5Y1.01%
EPS Q2Q%-10.32%
EPS Next Y-22.86%
EPS Next 2Y-6.14%
EPS Next 3Y-2.27%
EPS Next 5Y1.36%
Revenue 1Y (TTM)0.16%
Revenue growth 3Y-0.01%
Revenue growth 5Y1.11%
Sales Q2Q%-0.77%
Revenue Next Year-7.99%
Revenue Next 2Y-1.73%
Revenue Next 3Y-0.22%
Revenue Next 5Y1.1%
EBIT growth 1Y-13.41%
EBIT growth 3Y18.51%
EBIT growth 5Y-1.39%
EBIT Next Year5.54%
EBIT Next 3Y7.17%
EBIT Next 5Y6.13%
FCF growth 1Y-19.9%
FCF growth 3Y12.46%
FCF growth 5Y-10.05%
OCF growth 1Y-14.7%
OCF growth 3Y7.67%
OCF growth 5Y-8.7%

CLOROX COMPANY / CLX FAQ

Can you provide the ChartMill fundamental rating for CLOROX COMPANY?

ChartMill assigns a fundamental rating of 4 / 10 to CLX.


What is the valuation status for CLX stock?

ChartMill assigns a valuation rating of 2 / 10 to CLOROX COMPANY (CLX). This can be considered as Overvalued.


What is the profitability of CLX stock?

CLOROX COMPANY (CLX) has a profitability rating of 6 / 10.


What are the PE and PB ratios of CLOROX COMPANY (CLX) stock?

The Price/Earnings (PE) ratio for CLOROX COMPANY (CLX) is 18.2 and the Price/Book (PB) ratio is -661.8.


How sustainable is the dividend of CLOROX COMPANY (CLX) stock?

The dividend rating of CLOROX COMPANY (CLX) is 7 / 10 and the dividend payout ratio is 76.11%.